Chuck Carlson
CEO of Horizon Investment Services
Publisher of the
Dow Theory Forecasts Newsletter and
Author of "Winning with the Dow's Losers"
Hammond, IN
American Express: AXP – credit card debt is expected to be the next shoe to drop, which has impacted AXP. The company recently filed to become a bank holding company to give them access to government bailout dough, which sent a bad signal. Only middling Quadrix scores (Quadrix is our firm’s stock-rating system). We would be a seller
Intel: INTC – Stock getting beaten up with Tech downturn. Concerns about consumer and corporate spending on technology weighing on stock. Still, stock has a history of rebounding strongly. Quadrix score puts it in top quintile of 5000 stocks. We would hold the stock and consider buying for long-term investors.
Merck: MRK – Not a huge fan of most drug stocks. Weak product pipelines hurting the group. Merck’s Quadrix scores only average. I think there are better stocks in group (AstraZeneca to name one). We would sell and buy better names.
E-Mail Story
Print Story
